2
PyMT breast tumour: 50 g

(PDF) Harnett, N.G., Joshi, S., Kumar, P., Russell, C., Dillon, D.G., Baker, J.T., Pizzagalli, D.A., Kaufman, M.L., Nickerson, L.N., Jahanshad, N., Salminen, L.E., Thomopoulos, S.I., Frijling, J.L., Veltman, D.J., Koch, S.B.J., Nawijn, L., van Zuiden, M., Zhu, Y., Li, G., Ipser, J., Zhu, X., Ravid, O., Zilcha-Mano, S., Lazarov, A., Suarez-Jimenez, B., Sun, D., Hussain, A., Huggins, A.A., Jovanovic, T., van Rooij, S.J.H., Fani, N., Hudson, A.R., Sierk, A., Manthey, A., Walter, H., van der Wee, N.J.A., van der Werff, S.J.A., Vermeiren, R.R.J.M., ha, P., Lebois, L.A.M., Rosso, I.M., Olson, E.A., Liberzon, I., Angstadt, M., Disner, S.G., Sponheim, S.R., Koopowitz, S.M., Hofmann, D., Qi, R., Maron-Katz, A., Kunch, A., Xie, H., El-Hage, W., Berg, H., Bruce, S.E., McLaughlin, K.A., Peverill, M., Sambrook, K., Ross, M., Herringa, R.J., Nitschke, J.B., Davidson, R.J., deRoon-Cassini, T.A., Tomas, C.W., Fitzgerald, J.M., Blackford, J.U., Olatunji, B.O., Nelson, S.M., Gordon, E.M., Densmore, M., Thberge, J., Neufeld, R.W.J., Olff, M., Wang, L., Stein, D.J., Neria, Y., Stevens, J.S., Mueller, S.C., Daniels, J.K., Rektor, I., King, A., Davenport, N.D., Straube, T., Lu, G., Etkin, A., Wang, X., Quid, Y., Lissek, S., Cisler, J., Grupe, D.W., Larson, C., Feola, B., May, G., Abdallah, C.G., Lanius, R., Thompson, P.M., Morey, R.A., Ressler K

This is sterile water containing 0.9% benzyl alcohol, which acts as a preservative to prevent bacterial growth
2019 [updated 09 08 2019]
The findings below should therefore be interpreted as preclinical or preliminary clinical signals rather than established therapeutic evidence